AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. HISAMITSU PHARMACEUTICAL CO.,INC.
  3. Financials
  4. Revenue growth (%)

HISAMITSU PHARMACEUTICAL CO.,INC.【JP:4530】

Market cap
¥513.5B
P/E ratio
19.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Feb 28, 202510.1-3.17%
Feb 29, 202410.4+53.91%
Feb 28, 20236.8+36.49%
Feb 28, 20225-126.41%
Feb 28, 2021-18.8+1017.86%
Feb 29, 2020-1.7-44.37%
Feb 28, 2019-3-327.07%
Feb 28, 20181.3-113.52%
Feb 28, 2017-9.8-401.84%
Feb 29, 20163.3-19.51%
Feb 28, 20154.1-26.50%
Feb 28, 20145.5+52.63%
Feb 28, 20133.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)